Genetic Testing Brand Progenesis Enters the Indian Market

New Delhi, December 12,  2023 :  Progenesis, a globally renowned genetic testing brand based in the USA, has officially stepped into the Indian market with its first Genetic Laboratory in New Delhi and an AI & Bioinformatics Data Centre in Chennai.

The launch event, held today, witnessed the presence of prominent health experts, practitioners, and researchers from across the country, marking a significant milestone for Progenesis.

Progenesis has earned international acclaim for its groundbreaking genetic testing solutions, particularly in the field of In Vitro Fertilisation (IVF) treatment. The brand’s commitment to advancing reproductive genetics in India is underscored by its introduction of cutting-edge technology, unparalleled accuracy, and a dedication to customer-centric services.

Dr. Nabil Arrach, Founder & CEO, Progenesis, expressed his enthusiasm at the launch event, stating, “We are thrilled to bring Progenesis to India, a land of immense opportunity and possibilities. While our first laboratory has been established in Delhi, our goal is to establish a diverse market presence, reaching Tier 2 and 3 markets across the country.”

Progenesis, a tech-strong lab testing brand, aims to raise awareness about genetic diseases and disorders, leveraging advanced technologies, including Artificial Intelligence, to provide non-invasive and precise results to the Indian market.

In a move towards digital innovation, Progenesis has introduced the first online medical portal for Preimplantation Genetic Testing, streamlining the testing process for convenience and accessibility.

Addressing the opportunities in the Indian market, the experts discussed the vast potential in the Indian market for genetic testing, especially in the realm of reproductive health.

“The brand aims to collaborate with local healthcare providers, fertility clinics, and medical practitioners to expand its footprint and make advanced genetic testing solutions more accessible to a wider audience,” said Dr. Nabil Arrach.

The Indian market is witnessing a growing demand for innovative and reliable genetic testing services, and Progenesis is poised to address this need with its state-of-the-art facilities and expertise. The brand envisions playing a pivotal role in advancing the understanding and treatment of genetic disorders, contributing to improved outcomes in assisted reproductive technologies.

Corporate Comm India (CCI Newswire)

The Pharma Times News Bureau

Recent Posts

8 Ways Insomnia Affects Skin Health & How To Avoid It

By Dr. Priyanka Kuri, Consultant - Dermatology, Aster Whitefield Hospital, Bengaluru Insomnia, the persistent inability…

12 hours ago

Breaking New Ground in Migraine Care: A Landmark Session on Diagnosis and Treatment

Illuminating Latest Advances in Migraine Diagnosis and Treatment New Delhi, December 21, 2024: In a…

12 hours ago

Healthcare Startups to Watch Out for in 2025

New Delhi, December 20, 2024: The healthcare sector is undergoing a transformation fueled by technological…

2 days ago

DKMS’s First Global Impact Report of 2023 Serves as New Ray of Hope for Blood Cancer Patients Worldwide

National, December 20, 2024: DKMS just published its first Global Impact Report that outlines the organization's…

2 days ago

Sterling Biotech to start world’s first precision fermentation-based dairy protein factory in Gujarat

Ahmedabad, December 19, 2024: Sterling Biotech Limited, a joint venture between Perfect Day and Zydus, has…

2 days ago

Pioneers in Senior Care, Antara, Partners with Leading Diagnostics Player Dr. Lal PathLabs to Strengthen its Geriatric Care Services

New Delhi, December 19, 2024: Antara Senior Care, an integrated eco-system provider for lifestyle and…

2 days ago